单宁素抑制了小鼠室内灰尘引发的实验性喘的多个特征
相关实验视频
Updated: Jun 22, 2025

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.2K
Venkata Sita Rama Raju Allam1,2, Srinivas Akula1,2, Ida Waern2
1Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Inflammation
|July 3, 2024
概括
蒙宁素是一种向巨细胞的药物,在小鼠喘模型中表现出抗炎作用. 它减少了呼吸道炎症和巨细胞降粒,为新的喘治疗提供了潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 由于当前治疗方法的局限性,喘治疗需要新的策略.
- 乳腺细胞在过敏呼吸道炎症中起着至关重要的作用.
- 蒙素以其强大的抗杆细胞作用而闻名.
研究的目的:
- 在喘小鼠模型中研究单素的治疗潜力.
- 为了评估monensin对气道过敏反应和炎症标志物的影响.
- 评估monensin在过敏呼吸道炎症中对杆细胞脱粒化的作用.
主要方法:
- 在小鼠中使用室内灰尘虫 (HDM) 抗原诱导过敏气道炎症.
- 通过腹膜内注射和鼻内灌注给药.
- 评估呼吸道过敏反应,炎症细胞透,杯状细胞增生和基因表达.
- 评估呼吸道中巨细胞脱粒的情况.
主要成果:
- 单宁素没有抑制呼吸道过敏反应,但表现出显著的抗炎性质.
- 观察到,小氨基和淋巴细胞透到气道光线和肺组织炎症的减少.
- 鼻腔内蒙素抑制了杯状细胞增生和关键炎症标志物基因表达.
- 蒙宁素有效地阻断了对过敏原敏感的小鼠的乳腺细胞脱粒.
结论:
- 单素具有与过敏气道炎症相关的抗炎能力.
- 蒙宁素抑制巨细胞脱粒化的能力是其中的一个关键机制.
- 这项研究强调了素作为喘的潜在治疗剂.
相关概念视频
Asthma: Pathogenesis and Management
381
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
381
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
267
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
267
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Muscarinic Receptor Antagonists
280
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
280
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K

